Linked Data API

Show Search Form

Search Results

947011
registered interest false more like this
date less than 2018-07-23more like thismore than 2018-07-23
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading NHS: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether he has undertaken an impact assessment on the potential beneficial effects of regulating the dispensing of special medicinal products in England. more like this
tabling member constituency Central Ayrshire more like this
tabling member printed
Dr Philippa Whitford remove filter
uin 167294 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-09-04more like thismore than 2018-09-04
answer text <p>We have made no such assessment. The supply of special medicinal products is regulated in the United Kingdom by the Human Medicines Regulations 2012. In addition, in England, NHS dispensing by pharmacies is regulated by the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-09-04T16:00:47.033Zmore like thismore than 2018-09-04T16:00:47.033Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4385
label Biography information for Dr Philippa Whitford more like this